Crenolanib for treating FLT3 mutated proliferative disorders relapsed/refractory to prior… Grant US-11857546-B2 United States of America 02 Jan 2024
CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM… Application WO-2023247634-A1 World Intellectual Property Organisation (WIPO) 28 Dec 2023
CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM… Application EP-4296280-A1 European Patent Office 27 Dec 2023
THERAPY ASSESSMENT FOR HEMATOPOIETIC CANCER Application WO-2023237236-A1 World Intellectual Property Organisation (WIPO) 14 Dec 2023
Treatment of acute myeloid leukemia (AML) with venetoclax failure Grant US-11793802-B2 United States of America 24 Oct 2023
Assays and methods for selecting a treatment regimen for a subject with leukemia Grant US-11746386-B2 United States of America 05 Sep 2023
EPITOPE ENGINEERING OF CELL-SURFACE RECEPTORS Application WO-2023159136-A2 World Intellectual Property Organisation (WIPO) 24 Aug 2023
Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-11723905-B2 United States of America 15 Aug 2023
Approach for universal monitoring of minimal residual disease in acute myeloid leukemia Grant US-11709164-B2 United States of America 25 Jul 2023
PROTEOMICS-BASED STRATIFICATION OF ACUTE MYEOLID LEUKAEMIA Application WO-2023118199-A1 World Intellectual Property Organisation (WIPO) 29 Jun 2023
PROTEOMICS-BASED STRATIFICATION OF ACUTE MYELOID LEUKAEMIA Application EP-4202440-A1 European Patent Office 28 Jun 2023
METHOD FOR DETERMINING AML PROGNOSIS Application WO-2023111313-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2023
MITOCHONDRIAL GENOTYPE SCORES: PROGNOSTIC MARKERS IN CHEMOSENSITIVE CANCER Application WO-2023089268-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
MITOCHONDRIAL GENOTYPIC SCORES: PROGNOSTIC MARKERS IN CHEMO-SENSITIVE CANCER Application FR-3129155-A1 France 19 May 2023
Anti-CD70 and BCR-ABL inhibitor combination therapy Grant US-11571475-B1 United States of America 07 Feb 2023
TREATMENT OF HEMATOLOGICAL MALIGNANCY Application WO-2023002362-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2023
HUMAN PLACENTAL HEMATOPOIETIC STEM CELL DERIVED NATURAL KILLER CELLS IN ACUTE MYELOID… Application WO-2023278628-A1 World Intellectual Property Organisation (WIPO) 05 Jan 2023
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer Grant US-11530231-B2 United States of America 20 Dec 2022
DOSING REGIMENS FOR PROTEIN THERAPEUTICS Application WO-2022246244-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2022
AMPLICON DNA LIBRARY AND KIT FOR ACUTE MYELOID LEUKEMIA GENE PANEL TESTING, AND USE FOR… Application WO-2022239485-A1 World Intellectual Property Organisation (WIPO) 17 Nov 2022
Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation Grant US-11497743-B2 United States of America 15 Nov 2022
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1… Grant US-11497756-B2 United States of America 15 Nov 2022
METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS Application WO-2022162409-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2022
METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS Application WO-2022162088-A2 World Intellectual Property Organisation (WIPO) 04 Aug 2022
ADMINISTRATION AND DOSE REGIMEN FOR A COMBINATION OF A BCL-2 INHIBITOR AND A MCL1… Application WO-2022090443-A1 World Intellectual Property Organisation (WIPO) 05 May 2022
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) Grant US-11311527-B2 United States of America 26 Apr 2022
Alvocidib prodrugs and their use as protein kinase inhibitors Grant US-11279694-B2 United States of America 22 Mar 2022
NOVEL AGENTS AND USES THEREOF Application WO-2021111005-A1 World Intellectual Property Organisation (WIPO) 10 Jun 2021
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation Grant US-11013734-B2 United States of America 25 May 2021
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) Grant US-11013733-B2 United States of America 25 May 2021
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-10959994-B2 United States of America 30 Mar 2021
METHOD OF TREATMENT AND PRONOSTIC OF ACUTE MYELOID LEUKEMIA Application WO-2021044012-A1 World Intellectual Property Organisation (WIPO) 11 Mar 2021
Bispecific binding agent that binds to CD117/c-KIT and CD3 Application WO-2021044008-A1 World Intellectual Property Organisation (WIPO) 11 Mar 2021
Assays and methods for selecting a treatment regimen for a subject with leukemia Grant US-10927418-B2 United States of America 23 Feb 2021
POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS Application WO-2020252464-A1 World Intellectual Property Organisation (WIPO) 17 Dec 2020
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-10532047-B2 United States of America 14 Jan 2020
CHIMERIC ANTIGEN RECEPTORS (CAR)-EXPRESSING CELLS AND COMBINATION TREATMENT FOR… Application WO-2020007593-A1 World Intellectual Property Organisation (WIPO) 09 Jan 2020